enkephalin, leucine has been researched along with Peripheral Nerve Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, DJ; Hao, S; Hu, J | 1 |
| Buscher, D; Díaz, A; Hurlé, JM; Hurlé, MA; Izpisúa-Belmonte, JC; Lantero, A; Merino, D; Merino, R; Morchón, N; Tramullas, M; Villar, A | 1 |
| Alguacil, LF; Dilorenzo, L; Ezquerra, L; Franklin, B; Herradon, G; Nguyen, T; Rossenfeld, J; Silos-Santiago, I; Siso, A; Wang, C | 1 |
| Aley, KO; Levine, JD; Reichling, DB | 1 |
| Schäfer, M; Stein, C; Zhou, L | 1 |
5 other study(ies) available for enkephalin, leucine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Transgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic pain.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Enkephalins; Ganglia, Spinal; Gene Transfer Techniques; Genetic Vectors; Ligation; Lumbar Vertebrae; Male; Morphine; Morphine Dependence; Naloxone; Pain Threshold; Peripheral Nervous System Diseases; Protein Precursors; Rats; Rats, Sprague-Dawley; Simplexvirus; Spinal Nerve Roots; Substance Withdrawal Syndrome; Transgenes | 2009 |
BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor) reveals the involvement of the transforming growth factor-beta family in pain modulation.
Topics: Activins; Afferent Pathways; Animals; Bone Morphogenetic Protein 7; Cells, Cultured; Disease Models, Animal; Enkephalins; Hyperalgesia; Male; Membrane Proteins; Mice; Mice, Knockout; Narcotic Antagonists; Nociceptors; Pain Measurement; Pain Threshold; Peripheral Nerves; Peripheral Nervous System Diseases; Pro-Opiomelanocortin; Protein Precursors; Receptors, Opioid, delta; Sciatic Neuropathy; Signal Transduction; Spinal Cord; Transforming Growth Factor beta; Up-Regulation | 2010 |
Noradrenergic and opioidergic alterations in neuropathy in different rat strains.
Topics: Animals; Chronic Disease; Denervation; Disease Models, Animal; Down-Regulation; Dynorphins; Enkephalins; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Ligation; Male; Neurons, Afferent; Norepinephrine; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Protein Precursors; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, Opioid, delta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Species Specificity; Spinal Cord; Tyrosine 3-Monooxygenase | 2008 |
Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans.
Topics: Analgesics; Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hot Temperature; Hyperalgesia; Injections, Intravenous; Male; Neurons, Afferent; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Vincristine | 1996 |
Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue.
Topics: Analgesics, Opioid; Animals; Cholecystokinin; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Enzyme Inhibitors; Fentanyl; Male; Naphthalenes; Pain; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Protein Kinase C; Rats; Rats, Wistar; Receptors, Cholecystokinin | 1998 |